ConductScience.org, home

Paper25580906

Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.

Papadopoulou MV and 8 others. J Med Chem, 2015. Cited by 50 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents. Papers, record 25580906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25580906

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
PubMed
Journal
J Med Chem
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
2.54
iCite
Revised in PubMed
2018-11-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Papadopoulou MVMaria V
2Bloomer WDWilliam D
3Lepesheva GIGalina I
4Rosenzweig HSHoward S
5Kaiser MMarcel
6Aguilera-Venegas BBenjamín
7Wilkinson SRShane R
8Chatelain EEric
9Ioset JRJean-Robert

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmidesMajor topic
Chagas DiseaseMajor topic
MethanolMajor topic
TriazolesMajor topic
Trypanocidal AgentsMajor topic
Trypanosoma brucei rhodesienseMajor topic
Trypanosoma cruziMajor topic
Animals
Cell Line
Dose-Response Relationship, Drug
Mice
Mice, Inbred BALB C
Molecular Structure
Parasitic Sensitivity Tests
Rats
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 GM067871NIGMS NIH HHSUnited StatesR01GM067871PubMed and NIH
GM067871NIGMS NIH HHSUnited StatesR01GM067871PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119753490Ergosterol biosynthesis and drug development for Chagas disease.Mem Inst Oswaldo Cruz2009https://conductscience.org/library/papers/19753490PubMed
223448316Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth.J Med Chem2013https://conductscience.org/library/papers/23448316PubMed
318022567Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.Chem Biol2007https://conductscience.org/library/papers/18022567PubMed
420399979Chagas disease.Lancet2010https://conductscience.org/library/papers/20399979PubMed
520530488Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi.J Biol Chem2010https://conductscience.org/library/papers/20530488PubMed
623372180VNI cures acute and chronic experimental Chagas disease.J Infect Dis2013https://conductscience.org/library/papers/23372180PubMed
722023653Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.J Med Chem2011https://conductscience.org/library/papers/22023653PubMed
818769951CYP51: A major drug target in the cytochrome P450 superfamily.Lipids2008https://conductscience.org/library/papers/18769951PubMed
922550999Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.J Med Chem2012https://conductscience.org/library/papers/22550999PubMed
107479555Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans.Pharm Res1995https://conductscience.org/library/papers/7479555PubMed
1122948871Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22948871PubMed
1223504044CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds.Int J Parasitol Drugs Drug Resist2012https://conductscience.org/library/papers/23504044PubMed
1324012457Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.Bioorg Med Chem2013https://conductscience.org/library/papers/24012457PubMed
1421912715Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening.PLoS Negl Trop Dis2011https://conductscience.org/library/papers/21912715PubMed
1520028822Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20028822PubMed
1618367671A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18367671PubMed
1724144412Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.Future Med Chem2013https://conductscience.org/library/papers/24144412PubMed
1823916507Evaluating the developmental toxicity of trypanocidal nitroaromatic compounds on zebrafish.Acta Trop2013https://conductscience.org/library/papers/23916507PubMed
1920161970Inhibitory activity of marine sponge-derived natural products against parasitic protozoa.Mar Drugs2010https://conductscience.org/library/papers/20161970PubMed
2021093499Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6.Mol Biochem Parasitol2011https://conductscience.org/library/papers/21093499PubMed

See all 34 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
41976152Biphenyl as a Privileged Structure in Medicinal Chemistry: Advances in Anti-Infective Drug Discovery.Molecules2026https://conductscience.org/library/papers/41976152PubMed
38930921Fluconazole Analogs and Derivatives: An Overview of Synthesis, Chemical Transformations, and Biological Activity.Molecules2024https://conductscience.org/library/papers/38930921PubMed
38005183Anti-Trypanosoma cruzi Activity, Mutagenicity, Hepatocytotoxicity and Nitroreductase Enzyme Evaluation of 3-Nitrotriazole, 2-Nitroimidazole and Triazole Derivatives.Molecules2023https://conductscience.org/library/papers/38005183PubMed
34299579Chromenol Derivatives as Novel Antifungal Agents: Synthesis, In Silico and In Vitro Evaluation.Molecules2021https://conductscience.org/library/papers/34299579PubMed
32771798An insight on medicinal attributes of 1,2,4-triazoles.Eur J Med Chem2020https://conductscience.org/library/papers/32771798PubMed
32557280Planning new Trypanosoma cruzi CYP51 inhibitors using QSAR studies.Mol Divers2021https://conductscience.org/library/papers/32557280PubMed
32550995Construction and Evaluation of Molecular Models: Guide and Design of Novel SE Inhibitors.ACS Med Chem Lett2020https://conductscience.org/library/papers/32550995PubMed
32542530Fluconazole analogues with metal-binding motifs impact metal-dependent processes and demonstrate antifungal activity in Candida albicans.J Biol Inorg Chem2020https://conductscience.org/library/papers/32542530PubMed
31862616Current trends in the pharmacological management of Chagas disease.Int J Parasitol Drugs Drug Resist2020https://conductscience.org/library/papers/31862616PubMed
31427977Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains.Front Pharmacol2019https://conductscience.org/library/papers/31427977PubMed
31181717Quantitative Structure-Activity Relationships for Structurally Diverse Chemotypes Having Anti-Trypanosoma cruzi Activity.Int J Mol Sci2019https://conductscience.org/library/papers/31181717PubMed
29488127Combined Strategies to Improve the Expression of Recombinant Sterol C24-Methyltransferase from Leishmania braziliensis in E. coli.Mol Biotechnol2018https://conductscience.org/library/papers/29488127PubMed
28242662Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment In Vivo Assay.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28242662PubMed
27543881Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity.Eur J Med Chem2016https://conductscience.org/library/papers/27543881PubMed
27139467Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27139467PubMed
27092415Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.Eur J Med Chem2016https://conductscience.org/library/papers/27092415PubMed
26643331
Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi.
Antimicrob Agents Chemother2016https://conductscience.org/library/papers/26643331PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25580906

GET https://conductscience.org/api/papers/v1/25580906/references?page=2